N.J. High Court Refuses to Review Reversal of $25.1 Million Accutane Verdict



DOCUMENTS
  • Appellate Opinion


NEWARK, N.J. — The New Jersey Supreme Court will not review an appellate court’s reversal of a $25.1 million Accutane verdict in a case in which an Alabama man claims the acne drug caused his inflammatory bowel disease.

Pursuant to an order released on July 23, the plaintiff’s failure-to-warn claims will be retried in the Atlantic County Superior Court on the issues of causation and learned intermediary.

Alabama resident Andrew McCarrell sued Hoffman-La Roche, alleging that he developed IBD as a result of taking Accutane when he was in his early 20s. Shortly after discontinuing his use of the drug, …

FIRM NAMES
  • Beggs & Lane
  • Covington & Burling
  • Dughi Hewit & Domalewski
  • Gibbons
  • Hook & Bolton
  • Seeger Weiss





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS